TherapeuticsMD Net Profit Margin 2012-2020 | TXMD

TherapeuticsMD net profit margin from 2012 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
TherapeuticsMD Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.06B $-0.19B -301.59%
2020-03-31 $0.06B $-0.19B -332.76%
2019-12-31 $0.05B $-0.18B -352.00%
2019-09-30 $0.04B $-0.17B -425.64%
2019-06-30 $0.02B $-0.17B -944.44%
2019-03-31 $0.02B $-0.15B -925.00%
2018-12-31 $0.02B $-0.13B -825.00%
2018-09-30 $0.02B $-0.11B -760.00%
2018-06-30 $0.02B $-0.09B -581.25%
2018-03-31 $0.02B $-0.08B -500.00%
2017-12-31 $0.02B $-0.08B -481.25%
2017-09-30 $0.02B $-0.08B -493.75%
2017-06-30 $0.02B $-0.09B -494.44%
2017-03-31 $0.02B $-0.09B -500.00%
2016-12-31 $0.02B $-0.09B -473.68%
2016-09-30 $0.02B $-0.08B -400.00%
2016-06-30 $0.02B $-0.08B -390.00%
2016-03-31 $0.02B $-0.08B -400.00%
2015-12-31 $0.02B $-0.08B -420.00%
2015-09-30 $0.02B $-0.08B -461.11%
2015-06-30 $0.02B $-0.08B -482.35%
2015-03-31 $0.02B $-0.07B -412.50%
2014-12-31 $0.02B $-0.05B -360.00%
2014-09-30 $0.01B $-0.05B -328.57%
2014-06-30 $0.01B $-0.04B -300.00%
2014-03-31 $0.01B $-0.03B -310.00%
2013-12-31 $0.01B $-0.03B -311.11%
2013-09-30 $0.01B $-0.03B -371.43%
2013-06-30 $0.01B $-0.02B -366.67%
2013-03-31 $0.01B $-0.03B -560.00%
2012-12-31 $0.00B $-0.04B -875.00%
2012-09-30 $0.00B $-0.04B -975.00%
2012-06-30 $0.00B $-0.04B -900.00%
2012-03-31 $0.00B $-0.03B -625.00%
2011-12-31 $0.00B $-0.01B -433.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.414B $0.050B
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.154B 43.89
Takeda Pharmaceutical (TAK) Japan $52.462B 9.14
Astellas Pharma (ALPMY) Japan $26.307B 0.00
Eisai (ESALY) Japan $23.722B 20.05
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $19.677B 25.81
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.365B 49.95
Grifols, S.A (GRFS) Spain $12.513B 15.29
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.002B 34.85
Jazz Pharmaceuticals (JAZZ) Ireland $8.384B 13.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.439B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.592B 41.76
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $5.990B 0.00
United Therapeutics (UTHR) United States $5.423B 12.54
Evotec AG (EVTCY) Germany $4.189B 145.40
FibroGen (FGEN) United States $4.121B 0.00
ChemoCentryx (CCXI) United States $3.788B 0.00
Sage Therapeutics (SAGE) United States $3.681B 0.00
PTC Therapeutics (PTCT) United States $3.519B 0.00
Hypermarcas (HYPMY) Brazil $3.452B 12.70
Nektar Therapeutics (NKTR) United States $3.074B 0.00
Revolution Medicines (RVMD) United States $2.601B 0.00
Pacira BioSciences (PCRX) United States $2.321B 61.02
Taro Pharmaceutical Industries (TARO) Israel $2.284B 11.06
Xencor (XNCR) United States $2.261B 0.00
Cronos Group (CRON) Canada $2.124B 0.00
Corcept Therapeutics (CORT) United States $2.052B 18.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.921B 0.00
USANA Health Sciences (USNA) United States $1.765B 15.55
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.624B 15.49
Ironwood Pharmaceuticals (IRWD) United States $1.518B 10.54
Heron Therapeutics (HRTX) United States $1.494B 0.00
Endo (ENDP) Ireland $1.331B 1.97
Trillium Therapeutics (TRIL) Canada $1.307B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.217B 0.00
Zogenix (ZGNX) United States $1.164B 0.00
Karyopharm Therapeutics (KPTI) United States $1.134B 0.00
Translate Bio (TBIO) United States $1.074B 0.00
Indivior (INVVY) United States $1.055B 13.07
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
ImmunoGen (IMGN) United States $0.960B 0.00
Esperion Therapeutics (ESPR) United States $0.886B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.877B 545.88
Tilray (TLRY) Canada $0.869B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.678B 0.00
Collegium Pharmaceutical (COLL) United States $0.659B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.28
Radius Health (RDUS) United States $0.630B 0.00
Flexion Therapeutics (FLXN) United States $0.599B 0.00
VAXART, INC (VXRT) United States $0.597B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.519B 55.33
Molecular Templates (MTEM) United States $0.489B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.480B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Akebia Therapeutics (AKBA) United States $0.470B 0.00
Aerie Pharmaceuticals (AERI) United States $0.450B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Organogenesis Holdings (ORGO) United States $0.419B 0.00
Altimmune (ALT) United States $0.384B 0.00
Harpoon Therapeutics (HARP) United States $0.378B 0.00
DURECT (DRRX) United States $0.377B 0.00
Concert Pharmaceuticals (CNCE) United States $0.359B 0.00
Redhill Biopharma (RDHL) Israel $0.358B 0.00
Profound Medical (PROF) Canada $0.353B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.329B 8.15
Jounce Therapeutics (JNCE) United States $0.325B 15.40
Menlo Therapeutics (VYNE) United States $0.322B 0.00
MEI Pharma (MEIP) United States $0.314B 0.00
Innate Pharma SA (IPHYF) France $0.311B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.304B 0.00
Lannett Co Inc (LCI) United States $0.283B 6.58
KalVista Pharmaceuticals (KALV) United States $0.282B 0.00
Rafael Holdings (RFL) United States $0.266B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.255B 0.00
Aduro Biotech (KDNY) United States $0.250B 0.00
CTI BioPharma (CTIC) United States $0.246B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
IMV INC (IMV) Canada $0.231B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.02
CASI Pharmaceuticals (CASI) United States $0.198B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Aquestive Therapeutics (AQST) United States $0.179B 0.00
Otonomy (OTIC) United States $0.177B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Heat Biologics (HTBX) United States $0.175B 0.00
OptiNose (OPTN) United States $0.174B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.167B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
MediWound (MDWD) Israel $0.097B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.085B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.078B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.073B 0.00
Novan (NOVN) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.071B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.070B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Biomerica (BMRA) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.060B 0.00
Onconova Therapeutics (ONTX) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
Recro Pharma (REPH) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.27
Forward Pharma (FWP) Denmark $0.044B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
GTx (ONCT) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
Vical (BBI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 26.27
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.015B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00